Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.910 AUD | +0.26% |
|
+0.26% | +4.55% |
14/07 | Canaccord Genuity Downgrades Johns Lyng Group to Hold from Buy; Price Target is AU$4 | MT |
12/07 | Global markets live: Tesla, Nvidia, Google, BP, Nissan… | ![]() |
Fiscal Period: June | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 11 | 11.19 | 9.53 | 8.37 | 7.86 | |||||
Return on Total Capital | 25.78 | 26.19 | 17.27 | 13.75 | 12.17 | |||||
Return On Equity % | 42.91 | 41.45 | 18.93 | 17.28 | 14.81 | |||||
Return on Common Equity | 32.74 | 31.63 | 13.03 | 13.81 | 11.86 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 20.33 | 21.04 | 21.96 | 21.47 | 24.96 | |||||
SG&A Margin | 12.05 | 11.97 | 12.51 | 12.11 | 13.9 | |||||
EBITDA Margin % | 7.52 | 8.43 | 8.63 | 8.45 | 10.22 | |||||
EBITA Margin % | 6.73 | 7.62 | 7.83 | 7.67 | 8.88 | |||||
EBIT Margin % | 6.63 | 7.53 | 7.65 | 7.45 | 8.53 | |||||
Income From Continuing Operations Margin % | 4.48 | 4.83 | 4.3 | 4.9 | 5.46 | |||||
Net Income Margin % | 3.2 | 3.27 | 2.81 | 3.66 | 4.14 | |||||
Net Avail. For Common Margin % | 3.2 | 3.27 | 2.81 | 3.66 | 4.14 | |||||
Normalized Net Income Margin | 2.64 | 2.91 | 3.12 | 3.3 | 3.69 | |||||
Levered Free Cash Flow Margin | 10.77 | 3.79 | 2.94 | 9.03 | 3.02 | |||||
Unlevered Free Cash Flow Margin | 11.02 | 4 | 3.1 | 9.22 | 3.31 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 2.66 | 2.38 | 1.99 | 1.8 | 1.47 | |||||
Fixed Assets Turnover | 21.82 | 20.54 | 24.42 | 23.4 | 18.5 | |||||
Receivables Turnover (Average Receivables) | 5.97 | 5.56 | 4.89 | 5.21 | 4.86 | |||||
Inventory Turnover (Average Inventory) | 293.5 | 334.92 | 387.07 | 304.36 | 208.8 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 1.08 | 1.13 | 1.15 | 1.25 | 1.27 | |||||
Quick Ratio | 1.06 | 1.1 | 1.12 | 1.22 | 1.23 | |||||
Operating Cash Flow to Current Liabilities | 0.37 | 0.19 | 0.09 | 0.44 | 0.11 | |||||
Days Sales Outstanding (Average Receivables) | 61.29 | 65.67 | 74.64 | 70.12 | 75.3 | |||||
Days Outstanding Inventory (Average Inventory) | 1.25 | 1.09 | 0.94 | 1.2 | 1.75 | |||||
Average Days Payable Outstanding | 56.81 | 63.03 | 59.42 | 55.12 | 61.36 | |||||
Cash Conversion Cycle (Average Days) | 5.72 | 3.73 | 16.16 | 16.2 | 15.7 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 65.07 | 45.22 | 16.8 | 21.52 | 16.5 | |||||
Total Debt / Total Capital | 39.42 | 31.14 | 14.39 | 17.71 | 14.16 | |||||
LT Debt/Equity | 49.4 | 30.59 | 8.89 | 15.85 | 11.41 | |||||
Long-Term Debt / Total Capital | 29.93 | 21.07 | 7.61 | 13.05 | 9.8 | |||||
Total Liabilities / Total Assets | 74.24 | 70.44 | 48.76 | 49.82 | 41.45 | |||||
EBIT / Interest Expense | 16.8 | 22.85 | 29.97 | 25.22 | 18.1 | |||||
EBITDA / Interest Expense | 20.92 | 27.9 | 36.52 | 30.75 | 23.51 | |||||
(EBITDA - Capex) / Interest Expense | 20.46 | 26.58 | 33.84 | 27.28 | 22.08 | |||||
Total Debt / EBITDA | 0.94 | 0.64 | 0.67 | 0.73 | 0.59 | |||||
Net Debt / EBITDA | -0.2 | -0.19 | -0.01 | -0.39 | 0.02 | |||||
Total Debt / (EBITDA - Capex) | 0.96 | 0.67 | 0.72 | 0.82 | 0.63 | |||||
Net Debt / (EBITDA - Capex) | -0.21 | -0.2 | -0.01 | -0.44 | 0.02 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | 47.76 | 14.8 | 57.47 | 43.16 | -9.56 | |||||
Gross Profit, 1 Yr. Growth % | 48 | 18.81 | 64.35 | 39.97 | 5.13 | |||||
EBITDA, 1 Yr. Growth % | 73.88 | 28.75 | 61.17 | 40.2 | 9.32 | |||||
EBITA, 1 Yr. Growth % | 83.82 | 29.87 | 61.95 | 40.24 | 4.61 | |||||
EBIT, 1 Yr. Growth % | 81.01 | 30.33 | 60.01 | 40.09 | 3.51 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | 42.14 | 23.71 | 40.07 | 64.32 | 0.75 | |||||
Net Income, 1 Yr. Growth % | 20.35 | 17.1 | 35.32 | 88.31 | 2.49 | |||||
Normalized Net Income, 1 Yr. Growth % | 54.81 | 30.3 | 69.06 | 92.42 | 1.26 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | 20.07 | 16.15 | 24.55 | 75.29 | -3.3 | |||||
Accounts Receivable, 1 Yr. Growth % | 20.36 | 25.8 | 121.24 | 1.36 | -7.58 | |||||
Inventory, 1 Yr. Growth % | 122.69 | -55.53 | 237.45 | 37.5 | 17.61 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | 41.45 | 8.12 | 54.94 | 45.8 | -7.11 | |||||
Total Assets, 1 Yr. Growth % | 59.87 | 8.27 | 161.67 | 22.72 | 0.07 | |||||
Tangible Book Value, 1 Yr. Growth % | -96.81 | 1.44K | 133.87 | 50.7 | 17.79 | |||||
Common Equity, 1 Yr. Growth % | 15.12 | 26.55 | 388.01 | 12.21 | 25.72 | |||||
Cash From Operations, 1 Yr. Growth % | 165.16 | -44.03 | -9.96 | 455.71 | -79.16 | |||||
Capital Expenditures, 1 Yr. Growth % | 285.84 | 174.08 | 148.62 | 114.72 | -41.04 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | 216.97 | -59.62 | 22.12 | 585.5 | -69.77 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | 211.42 | -58.38 | 22.11 | 544.98 | -67.49 | |||||
Dividend Per Share, 1 Yr. Growth % | 33.33 | 25 | 14 | 57.89 | 4.44 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | 30.58 | 30.24 | 34.45 | 50.14 | 13.79 | |||||
Gross Profit, 2 Yr. CAGR % | 28.82 | 32.6 | 39.74 | 51.67 | 21.3 | |||||
EBITDA, 2 Yr. CAGR % | 27.1 | 49.62 | 44.05 | 50.32 | 23.8 | |||||
EBITA, 2 Yr. CAGR % | 28.02 | 54.51 | 45.02 | 50.7 | 21.12 | |||||
EBIT, 2 Yr. CAGR % | 27.03 | 53.59 | 44.41 | 49.38 | 20.42 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | 23.44 | 32.61 | 31.64 | 51.24 | 28.67 | |||||
Net Income, 2 Yr. CAGR % | 21.45 | 18.71 | 25.88 | 58.87 | 38.92 | |||||
Normalized Net Income, 2 Yr. CAGR % | 41.71 | 39.93 | 48.42 | 60.09 | 39.48 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | 14.93 | 18.09 | 20.28 | 47.04 | 30.2 | |||||
Accounts Receivable, 2 Yr. CAGR % | 30.56 | 23.05 | 66.83 | 47.48 | -3.21 | |||||
Inventory, 2 Yr. CAGR % | 74.24 | -0.48 | 22.51 | 115.41 | 27.17 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | 69.47 | 23.67 | 29.43 | 50.3 | 16.38 | |||||
Total Assets, 2 Yr. CAGR % | 54.08 | 31.56 | 68.31 | 77.84 | 10.82 | |||||
Tangible Book Value, 2 Yr. CAGR % | -80.97 | -29.96 | 499.9 | 108.63 | 33.23 | |||||
Common Equity, 2 Yr. CAGR % | 22.35 | 20.7 | 148.51 | 133.92 | 18.77 | |||||
Cash From Operations, 2 Yr. CAGR % | 73.92 | 21.82 | -29.01 | 123.68 | 7.61 | |||||
Capital Expenditures, 2 Yr. CAGR % | 115.27 | 225.19 | 161.04 | 131.05 | 12.51 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | 358.93 | 13.14 | -29.77 | 131.76 | 43.95 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | 328.47 | 13.85 | -28.71 | 128.01 | 44.81 | |||||
Dividend Per Share, 2 Yr. CAGR % | 45.1 | 29.1 | 19.37 | 34.16 | 28.42 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | 25.63 | 25.09 | 38.75 | 37.29 | 26.8 | |||||
Gross Profit, 3 Yr. CAGR % | 26.12 | 25.39 | 42.44 | 39.82 | 34.23 | |||||
EBITDA, 3 Yr. CAGR % | 29.24 | 27.65 | 53.38 | 42.76 | 35.18 | |||||
EBITA, 3 Yr. CAGR % | 29.75 | 28.63 | 56.95 | 43.41 | 33.43 | |||||
EBIT, 3 Yr. CAGR % | 29.09 | 28.12 | 55.7 | 42.74 | 32.19 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | 18.61 | 23.53 | 35.05 | 41.44 | 32.09 | |||||
Net Income, 3 Yr. CAGR % | 16.07 | 19.98 | 24.01 | 43.51 | 37.27 | |||||
Normalized Net Income, 3 Yr. CAGR % | 33.66 | 36.44 | 49.04 | 49.47 | 37.35 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | 2.3 | 15.34 | 20.21 | 35.92 | 27.87 | |||||
Accounts Receivable, 3 Yr. CAGR % | 22.6 | 28.96 | 49.63 | 39.87 | 26.2 | |||||
Inventory, 3 Yr. CAGR % | 33.31 | 10.53 | 49.51 | 27.31 | 76.06 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 52.52 | 45.89 | 33.32 | 34.67 | 28.03 | |||||
Total Assets, 3 Yr. CAGR % | 45.32 | 36.98 | 65.45 | 50.72 | 46.82 | |||||
Tangible Book Value, 3 Yr. CAGR % | -59.83 | -17.7 | 4.69 | 306.11 | 72.43 | |||||
Common Equity, 3 Yr. CAGR % | 54.49 | 23.73 | 92.29 | 90.6 | 90.18 | |||||
Cash From Operations, 3 Yr. CAGR % | 61.35 | 19.18 | 10.14 | 40.95 | 1.4 | |||||
Capital Expenditures, 3 Yr. CAGR % | 8.39 | 133.32 | 197.35 | 144.59 | 46.55 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | 72.78 | 104.13 | 16.06 | 29.45 | 17.54 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | 78.14 | 96.97 | 16.54 | 29.35 | 19.12 | |||||
Dividend Per Share, 3 Yr. CAGR % | - | 38.06 | 23.86 | 31.04 | 23.42 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | 16.79 | 18.59 | 29.08 | 34.57 | 28.17 | |||||
Gross Profit, 5 Yr. CAGR % | 16.98 | 17.57 | 31.4 | 35.31 | 33.58 | |||||
EBITDA, 5 Yr. CAGR % | 39.36 | 17.48 | 34.98 | 36.27 | 40.78 | |||||
EBITA, 5 Yr. CAGR % | 42.19 | 17.04 | 35.66 | 37.04 | 41.5 | |||||
EBIT, 5 Yr. CAGR % | 41.76 | 16.76 | 35.01 | 36.24 | 40.37 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | 50.99 | 10.53 | 23.66 | 33.95 | 32.3 | |||||
Net Income, 5 Yr. CAGR % | 41.15 | 8.11 | 19.9 | 34.24 | 29.52 | |||||
Normalized Net Income, 5 Yr. CAGR % | 42.51 | 19.95 | 38.56 | 45.45 | 38.38 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | 38.16 | 5.65 | 9.14 | 27.1 | 23.86 | |||||
Accounts Receivable, 5 Yr. CAGR % | 18.95 | 29.58 | 38.68 | 36.07 | 24.93 | |||||
Inventory, 5 Yr. CAGR % | -29.68 | -38.56 | 28.88 | 44.34 | 40.14 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 43.55 | 45.74 | 42.83 | 47.64 | 26.27 | |||||
Total Assets, 5 Yr. CAGR % | 19.84 | 24.29 | 54.12 | 52.06 | 40.52 | |||||
Tangible Book Value, 5 Yr. CAGR % | -38.94 | 2.68 | 18.45 | 19.4 | 20.26 | |||||
Common Equity, 5 Yr. CAGR % | 39.01 | 40.75 | 86.84 | 59.63 | 58.56 | |||||
Cash From Operations, 5 Yr. CAGR % | 142.93 | 13.33 | 16.18 | 53.31 | 9.12 | |||||
Capital Expenditures, 5 Yr. CAGR % | 9.6 | 33.46 | 54.05 | 132.41 | 101.58 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | 109.52 | 6.8 | 20.53 | 114.76 | 15.76 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | 135.87 | 7.19 | 23.5 | 108.84 | 16.99 | |||||
Dividend Per Share, 5 Yr. CAGR % | - | - | - | 36.49 | 25.66 |
- Stock Market
- Equities
- JLG Stock
- Financials Johns Lyng Group Limited
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions

MarketScreener is also available in this country: United States.
Switch edition